Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07400042 · ClinicalTrials.gov registry record · NA

Peripheral Venous Pressure (PVP) Trial

A NA study, sponsored by Wake Forest University Health Sciences.

Not yet
Registry status
NA
Development phase
600
Enrollment target

NCT07400042: Clinical Trial NA study, sponsored by Wake Forest University Health Sciences.

NCT07400042 is a NA study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 600 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07400042, a NA study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.

NOT YET RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target

Study Summary

The purpose of the study is to determine if there is a reduction in the length of stay and rates of rehospitalization for patients diagnosed with congestive heart failure when physicians are provided daily measurements of peripheral venous pressure versus no daily measurements of peripheral venous pressure.

Primary Outcome

Number of days from admission to discharge

Interventions

  • OTHER peripheral venous pressure measurements
  • OTHER standard clinical care

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2026-08
Est. Completion 2031-08
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What is known before NCT07400042 opens enrollment

NCT07400042 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).

The record links to 0 conditions, and to 2 interventions - of which peripheral venous pressure measurements is the first listed.

NCT07400042 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07400042 about?

NCT07400042 is a clinical study titled "Peripheral Venous Pressure (PVP) Trial". The purpose of the study is to determine if there is a reduction in the length of stay and rates of rehospitalization for patients diagnosed with congestive heart failure when physicians are provided daily measurements of peripheral venous pressure versus no daily measurements of peripheral venous p...

What is the current status of trial NCT07400042?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2026-08. Estimated completion is 2031-08.

What interventions are being tested in trial NCT07400042?

The interventions under investigation include: peripheral venous pressure measurements (OTHER), standard clinical care (OTHER).

Who is sponsoring clinical trial NCT07400042?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07400042's enrollment target sits among peer trials

600 162nd of 2000 higher than 1,827 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07400042, the US trial registry maintained by the National Library of Medicine. NCT07400042 (mid enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.